MetLife Investment Management’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.06M Sell
17,423
-440
-2% -$63.5K 0.01% 1044
2025
Q4
$3.17M Sell
17,863
-815
-4% -$144K 0.02% 837
2025
Q3
$3.21M Sell
18,678
-327
-2% -$52K 0.02% 852
2025
Q2
$2.93M Buy
19,005
+455
+2% +$58.8K 0.02% 808
2025
Q1
$1.94M Sell
18,550
-592
-3% -$62.7K 0.01% 1051
2024
Q4
$1.73M Buy
19,142
+1,087
+6% +$85.4K 0.01% 1118
2024
Q3
$1.34M Hold
18,055
0.01% 1224
2024
Q2
$1.94M Buy
18,055
+2,418
+15% +$247K 0.01% 986
2024
Q1
$1.81M Sell
15,637
-391
-2% -$44K 0.01% 996
2023
Q4
$1.72M Hold
16,028
0.01% 1010
2023
Q3
$1.51M Hold
16,028
0.01% 1029
2023
Q2
$1.67M Buy
16,028
+270
+2% +$32.4K 0.01% 1003
2023
Q1
$1.95M Sell
15,758
-334
-2% -$36.2K 0.01% 922
2022
Q4
$1.51M Hold
16,092
0.01% 1013
2022
Q3
$2.02M Buy
16,092
+620
+4% +$89.5K 0.02% 872
2022
Q2
$1.67M Sell
15,472
-306
-2% -$40.5K 0.01% 964
2022
Q1
$2.48M Buy
15,778
+5,205
+49% +$668K 0.02% 913
2021
Q4
$1.24M Hold
10,573
0.01% 1038
2021
Q3
$619K Hold
10,573
0.01% 1405
2021
Q2
$702K Hold
10,573
0.01% 1372
2021
Q1
$1.47M Sell
10,573
-889
-8% -$159K 0.01% 971
2020
Q4
$2.72M Hold
11,462
0.03% 679
2020
Q3
$2.73M Sell
11,462
-492
-4% -$87K 0.03% 585
2020
Q2
$1.39M Buy
11,954
+944
+9% +$104K 0.02% 889
2020
Q1
$896K Hold
11,010
0.01% 955
2019
Q4
$750K Hold
11,010
0.01% 1244
2019
Q3
$816K Hold
11,010
0.01% 1168
2019
Q2
$871K Hold
11,010
0.01% 1174
2019
Q1
$825K Hold
11,010
0.01% 1171
2018
Q4
$765K Hold
11,010
0.01% 1131
2018
Q3
$1.04M Buy
+11,010
New +$959K 0.01% 1102

Other funds holding IRTC

MetLife Investment Management's IRTC Position: Q1 2026 in Review

MetLife Investment Management reduced its iRhythm Holdings (IRTC) stake by 2.5% in Q1 2026, selling an estimated $63.5K and leaving 17,423 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #1044.

MetLife Investment Management first reported a position in IRTC in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.21M in Q3 2025. 304 funds tracked by Wall St. Rank hold IRTC as of Q1 2026.

  • MetLife Investment Management held 17,423 shares of iRhythm Holdings worth $2.06M as of Q1 2026.
  • MetLife Investment Management sold 440 iRhythm Holdings shares in Q1 2026, an estimated $63.5K.
  • iRhythm Holdings made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1044 holding.
  • MetLife Investment Management first reported a position in iRhythm Holdings in Q3 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's iRhythm Holdings position peaked at $3.21M in Q3 2025.
  • 304 funds tracked by Wall St. Rank held iRhythm Holdings as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.